Is there any difference between PEG-IFN a2a or a2b plus ribavirin for HCV patient in real life conditions.

ŞİRİN G., Şentürk Ö., ÇELEBİ A., HÜLAGÜ S.

23rd Annual Conference of APASL, Brisbane, Australia, 12 - 15 March 2014, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• City: Brisbane
• Country: Australia
• Kocaeli University Affiliated: Yes